NVE Corporation Earnings Call Transcripts
Fiscal Year 2026
-
Revenue grew 23% and earnings rose 11% year-over-year, driven by broad-based product and R&D growth, while gross margin declined due to mix shift. New equipment and a key supplier agreement support future growth, with optimism in medical, defense, and industrial markets.
-
Sequential revenue grew 4% on strong distributor and non-defense sales, while year-over-year revenue declined 6% due to lower contract R&D. Gross margin fell to 78%, net income dropped to $3.31M, and new products plus production expansion are expected to drive future growth.
-
Revenue and net income declined year-over-year due to lower defense sales, but distributor and non-defense sales improved as industry conditions stabilized. New sensor products and capital investments position the company for future growth, with sequential gains expected in defense-related business.
Fiscal Year 2025
-
Quarterly revenue grew 3% year-over-year and 44% sequentially, driven by a surge in contract R&D and product sales, with gross margin rising to 79%. Annual net income declined 12% due to earlier softness, but strong product launches and major CapEx are expected to drive future growth.
-
Earnings remained strong despite a 25% revenue decline, with gross margin rising to 84% due to higher direct sales and a favorable product mix. R&D investment and facility expansion support new product launches, while management is optimistic about improving industry conditions.
-
Quarterly revenue declined 5% year-over-year due to lower product sales, but gross margin rose to 86% and contract R&D revenue surged. Net income fell 15%, yet comprehensive income increased slightly. Management remains optimistic as inventory levels normalize and new products enter production.
-
Strong earnings and cash flow were achieved despite a 23% revenue decline, with gross margin rising to 86% and operating cash flow up 16%. Investments in advanced packaging and strong defense and electrification markets are expected to drive future growth.